Your browser doesn't support javascript.
loading
Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?
Tak Manesh, A; Azizi, G; Heydari, A; Kiaee, F; Shaghaghi, M; Hossein-Khannazer, N; Yazdani, R; Abolhassani, H; Aghamohammadi, A.
Afiliación
  • Tak Manesh, A; The Royal Australian College of General Practitioners (RACGP). Melbourne. Australia
  • Azizi, G; Alborz University of Medical Sciences. Imam hasan Mojtaba Hospital. Department of Laboratory Medicine. Karaj. Iran
  • Heydari, A; Tehran University of Medical Sciences. Children's Medical Center. Pediatrics Center of Excellence. Reseach Center for Immunodeficiencies. Tehran. Iran
  • Kiaee, F; Tehran University of Medical Sciences. Children's Medical Center. Pediatrics Center of Excellence. Reseach Center for Immunodeficiencies. Tehran. Iran
  • Shaghaghi, M; Tehran University of Medical Sciences. Children's Medical Center. Pediatrics Center of Excellence. Reseach Center for Immunodeficiencies. Tehran. Iran
  • Hossein-Khannazer, N; Shahid Behshti University of Medical Sciences. School of Medicine. Department of Imunology. Tehran. Iran
  • Yazdani, R; Isfahan University of Medical Sciences. School of Medicine. Department of Immunology. Isfahan. Iran
  • Abolhassani, H; Tehran University of Medical Sciences. Children's Medical Center. Pediatrics Center of Excellence. Reseach Center for Immunodeficiencies. Tehran. Iran
  • Aghamohammadi, A; Tehran University of Medical Sciences. Children's Medical Center. Pediatrics Center of Excellence. Reseach Center for Immunodeficiencies. Tehran. Iran
Allergol. immunopatol ; 45(6): 602-615, nov.-dic. 2017. tab, graf
Article en En | IBECS | ID: ibc-168469
Biblioteca responsable: ES1.1
Ubicación: BNCS
ABSTRACT
Common variable immunodeficiency (CVID) is a diagnostic category of primary immunodeficiency (PID) which may present with heterogeneous disorders including recurrent infections, autoimmunity, granulomatous diseases, lymphoid and other types of malignancies. Generally, the incidence of malignancy in CVID patients is around 1.5-20.7% and usually occurs during the 4th-6th decade of life. Non-Hodgkin lymphoma is the most frequent malignancy, followed by epithelial tumours of stomach, breast, bladder and cervix. The exact pathological mechanisms for cancer development in CVID are not fully determined; however, several mechanisms including impaired genetic stability, genetic predisposition, immune dysregulation, impaired clearance of oncogenic viruses and bacterial infections, and iatrogenic causes have been proposed to contribute to the high susceptibility of these patients to malignancies (AU)
RESUMEN
No disponible
Asunto(s)
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Inmunodeficiencia Variable Común / Linfoma / Neoplasias Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Allergol. immunopatol Año: 2017 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Inmunodeficiencia Variable Común / Linfoma / Neoplasias Tipo de estudio: Etiology_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Allergol. immunopatol Año: 2017 Tipo del documento: Article